{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:55:22Z","timestamp":1768625722910,"version":"3.49.0"},"reference-count":41,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a potentially preventable adverse side effect of mainly antiresorptive drugs. MRONJ is expected to become a growing clinical problem due to the aging population and the increasing number of patients requiring antiresorptive agents. Knowledge and awareness about MRONJ and elimination of the oral and dental risk factors before starting antiresorptive therapy (AR) are fundamental to reducing the incidence of MRONJ. In urology, ARs are used primarily in patients suffering from bone metastases due to prostate cancer and to prevent cancer-treatment-induced bone loss (CTIBL) in prostate cancer patients receiving endocrine therapy. This postal survey aimed to evaluate disease-related knowledge and awareness about implementing oral examinations for patients starting AR among Swiss, German, and Austrian urologists. A total of 176 urologists returned the completed questionnaire, yielding a response rate of 11.7%. Of the respondents, 44.9% (n = 79) and 24.4% (n = 43) stated that they give more than five first-time prescriptions of denosumab and of intravenous or oral bisphosphonates per year, respectively. Only 14.8% (n = 26) of the participating urologists had never encountered MRONJ cases related to BPs. Of the participants, 89.8% (n = 158) had implemented referrals to dentists for oral examination before initiating AR. The mean percentage of correct answers regarding the knowledge about MRONJ was 70.9% \u00b1 11.2%. In contrast to previous surveys on MRONJ among physicians, this study showed that the participating urologists were sufficiently informed about MRONJ, as reflected by the high number of participants implementing preventive dental screenings.<\/jats:p>","DOI":"10.3390\/jcm12020638","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:57:33Z","timestamp":1673578653000},"page":"638","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Survey among Urologists in Switzerland, Germany, and Austria"],"prefix":"10.3390","volume":"12","author":[{"given":"Salvatore","family":"Calderaro","sequence":"first","affiliation":[{"name":"Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Bausch","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"},{"name":"Department of Urology, University Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-4067","authenticated-orcid":false,"given":"C\u00e9line","family":"Tourbier","sequence":"additional","affiliation":[{"name":"Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"},{"name":"Medical Additive Manufacturing Research Group (Swiss MAM), Department of Biomedical Engineering, University of Basel, 4123 Allschwil, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wetterauer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"},{"name":"Department of Urology, University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Medicine, Faculty of Medicine and Dentistry, Danube Private University, 3500 Krems, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3035-9308","authenticated-orcid":false,"given":"Florian M.","family":"Thieringer","sequence":"additional","affiliation":[{"name":"Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"},{"name":"Medical Additive Manufacturing Research Group (Swiss MAM), Department of Biomedical Engineering, University of Basel, 4123 Allschwil, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0761","authenticated-orcid":false,"given":"Britt-Isabelle","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, 4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J. Oral0 Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1601-0825.2012.01911.x","article-title":"Non-exposed bisphosphonate-related osteonecrosis of the jaw: A critical assessment of current definition, staging, and treatment guidelines","volume":"18","author":"Patel","year":"2012","journal-title":"Oral. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: A comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int. J. Implant. Dent."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00774-019-01052-6","article-title":"Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma","volume":"38","author":"Jeon","year":"2020","journal-title":"J. Bone Miner Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1081\/CNV-120014886","article-title":"The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: A comparison to pamidronate","volume":"20","author":"Lipton","year":"2002","journal-title":"Cancer Investig."},{"key":"ref_10","first-page":"462","article-title":"The use of bisphosphonates in the treatment of osteoporosis","volume":"17","author":"Delmas","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","article-title":"Osteogenesis imperfecta: Advancements in genetics and treatment","volume":"31","author":"Rossi","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.amjmed.2018.04.028","article-title":"Paget\u2019s Disease of Bone: Diagnosis and Treatment","volume":"131","author":"Kravets","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: Current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","article-title":"The anti-tumor effect of RANKL inhibition in malignant solid tumors\u2014A systematic review","volume":"62","author":"Kroep","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.joms.2013.03.019","article-title":"Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma","volume":"71","author":"Folkmar","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oooo.2018.11.012","article-title":"Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review","volume":"127","author":"King","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014Characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00784-021-04261-4","article-title":"Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab","volume":"26","author":"Wick","year":"2022","journal-title":"Clin. Oral Investig."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Schwech, N., Nilsson, J., and Gabre, P. (2022). Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients\u2014A systematic review. Clin. Exp. Dent. Res.","DOI":"10.1002\/cre2.698"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jds.2022.03.014","article-title":"Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study","volume":"17","author":"Seki","year":"2022","journal-title":"J. Dent. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Aguirre, J.I., Castillo, E.J., and Kimmel, D.B. (2021). Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone, 153.","DOI":"10.1016\/j.bone.2021.116184"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41368-022-00182-4","article-title":"Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"14","author":"Yan","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/odi.13737","article-title":"Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients","volume":"28","author":"Wei","year":"2022","journal-title":"Oral Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner Res."},{"key":"ref_31","first-page":"e314","article-title":"Proposal for a preventive protocol for medication-related osteonecrosis of the jaw","volume":"26","year":"2021","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.33232","article-title":"Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050","volume":"148","author":"Pilleron","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/bcp.14681","article-title":"Medication-related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications","volume":"87","author":"Teoh","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1007\/s00520-020-05440-x","article-title":"Preventing, identifying, and managing medication-related osteonecrosis of the jaw: A practical guide for nurses and other allied healthcare professionals","volume":"28","author":"Demonty","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bruckmoser, E., Palaoro, M., Latzko, L., Schnabl, D., Neururer, S.B., and Laimer, J. (2021). Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know. Int. J. Environ Res. Public Health, 18.","DOI":"10.3390\/ijerph18094466"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1007\/s00520-020-05374-4","article-title":"Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals","volume":"28","author":"Montezuma","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Jeong, S.R., Kim, S.J., and Kim, Y. (2016). Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw. BMC Oral Health, 16.","DOI":"10.1186\/s12903-016-0290-0"},{"key":"ref_40","first-page":"830","article-title":"Physicians\u2019 awareness of bisphosphonates-related osteonecrosis of the jaw","volume":"32","author":"Mishriky","year":"2011","journal-title":"Saudi Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sturrock, A., Preshaw, P.M., Hayes, C., and Wilkes, S. (2019). Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): A qualitative study in England. BMJ Open, 9.","DOI":"10.1136\/bmjopen-2018-024376"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/638\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:56Z","timestamp":1760119496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12020638"],"URL":"https:\/\/doi.org\/10.3390\/jcm12020638","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]}}}